Cargando…

Fabrication of Polymeric Hydrogels Containing Esomeprazole for Oral Delivery: In Vitro and In Vivo Pharmacokinetic Characterization

Hydrogel is one of the most interesting and excellent candidates for oral drug delivery. The current study focuses on formulation development of hydrogels for controlled oral delivery of esomeprazole. The hydrogels were prepared by solution casting method by dissolving polymers in Polyvinyl alcohol...

Descripción completa

Detalles Bibliográficos
Autores principales: Ullah, Irshad, Farooq, Ayesha Shuja, Naz, Iffat, Ahmad, Waqar, Ullah, Hidayat, Sehar, Shama, Nawaz, Asif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097100/
https://www.ncbi.nlm.nih.gov/pubmed/37050412
http://dx.doi.org/10.3390/polym15071798
_version_ 1785024498413600768
author Ullah, Irshad
Farooq, Ayesha Shuja
Naz, Iffat
Ahmad, Waqar
Ullah, Hidayat
Sehar, Shama
Nawaz, Asif
author_facet Ullah, Irshad
Farooq, Ayesha Shuja
Naz, Iffat
Ahmad, Waqar
Ullah, Hidayat
Sehar, Shama
Nawaz, Asif
author_sort Ullah, Irshad
collection PubMed
description Hydrogel is one of the most interesting and excellent candidates for oral drug delivery. The current study focuses on formulation development of hydrogels for controlled oral delivery of esomeprazole. The hydrogels were prepared by solution casting method by dissolving polymers in Polyvinyl alcohol (PVA) solution. Calcium alginate, Hydroxyl propyl methylcellulose (HPMC), acrylic acid and chondroitin sulfate were used in the preparation of hydrogels. Fourier transform infrared (FTIR) analysis showed no incompatibilities between drug and excipients used in the preparation of formulations. The hydrogels were characterized for size and surface morphology. Drug encapsulation efficiency was measured by Ultraviolet-visible (UV-VIS) spectroscopy. In vitro release studies were carried out using dissolution apparatus. The formulated hydrogels were then compared with the marketed product in vivo using rabbits. The result indicates that prepared hydrogels have a uniform size with a porous surface. The esomeprazole encapsulation efficiency of the prepared hydrogels was found to be 83.1 ± 2.16%. The esomeprazole-loaded hydrogel formulations showed optimum and Pharmacopeial acceptable range swelling behavior. The release of esomeprazole is controlled for 24 h (85.43 ± 0.32% in 24 h). The swelling and release of drug results make the prepared hydrogels a potential candidate for the controlled delivery of esomeprazole. The release of the drug from prepared hydrogel followed the super case transport-2 mechanism. The in vivo studies showed that prepared hydrogel formulations showed controlled and prolonged release of esomeprazole as compared to drug solution and marketed product. The formulations were kept for stability studies; there was no significant change observed in physical parameters, i.e., (appearance, color change and grittiness) at 40 °C ± 2/75% ± RH. There was a negligible difference in the drug content observed after the stability study suggested that all the formulations are stable under the given conditions for 60 days. The current study provides a valuable perspective on the controlled release profile of Hydroxyl propyl methylcellulose (HPMC) and calcium alginate-based esomeprazole hydrogels.
format Online
Article
Text
id pubmed-10097100
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100971002023-04-13 Fabrication of Polymeric Hydrogels Containing Esomeprazole for Oral Delivery: In Vitro and In Vivo Pharmacokinetic Characterization Ullah, Irshad Farooq, Ayesha Shuja Naz, Iffat Ahmad, Waqar Ullah, Hidayat Sehar, Shama Nawaz, Asif Polymers (Basel) Article Hydrogel is one of the most interesting and excellent candidates for oral drug delivery. The current study focuses on formulation development of hydrogels for controlled oral delivery of esomeprazole. The hydrogels were prepared by solution casting method by dissolving polymers in Polyvinyl alcohol (PVA) solution. Calcium alginate, Hydroxyl propyl methylcellulose (HPMC), acrylic acid and chondroitin sulfate were used in the preparation of hydrogels. Fourier transform infrared (FTIR) analysis showed no incompatibilities between drug and excipients used in the preparation of formulations. The hydrogels were characterized for size and surface morphology. Drug encapsulation efficiency was measured by Ultraviolet-visible (UV-VIS) spectroscopy. In vitro release studies were carried out using dissolution apparatus. The formulated hydrogels were then compared with the marketed product in vivo using rabbits. The result indicates that prepared hydrogels have a uniform size with a porous surface. The esomeprazole encapsulation efficiency of the prepared hydrogels was found to be 83.1 ± 2.16%. The esomeprazole-loaded hydrogel formulations showed optimum and Pharmacopeial acceptable range swelling behavior. The release of esomeprazole is controlled for 24 h (85.43 ± 0.32% in 24 h). The swelling and release of drug results make the prepared hydrogels a potential candidate for the controlled delivery of esomeprazole. The release of the drug from prepared hydrogel followed the super case transport-2 mechanism. The in vivo studies showed that prepared hydrogel formulations showed controlled and prolonged release of esomeprazole as compared to drug solution and marketed product. The formulations were kept for stability studies; there was no significant change observed in physical parameters, i.e., (appearance, color change and grittiness) at 40 °C ± 2/75% ± RH. There was a negligible difference in the drug content observed after the stability study suggested that all the formulations are stable under the given conditions for 60 days. The current study provides a valuable perspective on the controlled release profile of Hydroxyl propyl methylcellulose (HPMC) and calcium alginate-based esomeprazole hydrogels. MDPI 2023-04-06 /pmc/articles/PMC10097100/ /pubmed/37050412 http://dx.doi.org/10.3390/polym15071798 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ullah, Irshad
Farooq, Ayesha Shuja
Naz, Iffat
Ahmad, Waqar
Ullah, Hidayat
Sehar, Shama
Nawaz, Asif
Fabrication of Polymeric Hydrogels Containing Esomeprazole for Oral Delivery: In Vitro and In Vivo Pharmacokinetic Characterization
title Fabrication of Polymeric Hydrogels Containing Esomeprazole for Oral Delivery: In Vitro and In Vivo Pharmacokinetic Characterization
title_full Fabrication of Polymeric Hydrogels Containing Esomeprazole for Oral Delivery: In Vitro and In Vivo Pharmacokinetic Characterization
title_fullStr Fabrication of Polymeric Hydrogels Containing Esomeprazole for Oral Delivery: In Vitro and In Vivo Pharmacokinetic Characterization
title_full_unstemmed Fabrication of Polymeric Hydrogels Containing Esomeprazole for Oral Delivery: In Vitro and In Vivo Pharmacokinetic Characterization
title_short Fabrication of Polymeric Hydrogels Containing Esomeprazole for Oral Delivery: In Vitro and In Vivo Pharmacokinetic Characterization
title_sort fabrication of polymeric hydrogels containing esomeprazole for oral delivery: in vitro and in vivo pharmacokinetic characterization
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097100/
https://www.ncbi.nlm.nih.gov/pubmed/37050412
http://dx.doi.org/10.3390/polym15071798
work_keys_str_mv AT ullahirshad fabricationofpolymerichydrogelscontainingesomeprazolefororaldeliveryinvitroandinvivopharmacokineticcharacterization
AT farooqayeshashuja fabricationofpolymerichydrogelscontainingesomeprazolefororaldeliveryinvitroandinvivopharmacokineticcharacterization
AT naziffat fabricationofpolymerichydrogelscontainingesomeprazolefororaldeliveryinvitroandinvivopharmacokineticcharacterization
AT ahmadwaqar fabricationofpolymerichydrogelscontainingesomeprazolefororaldeliveryinvitroandinvivopharmacokineticcharacterization
AT ullahhidayat fabricationofpolymerichydrogelscontainingesomeprazolefororaldeliveryinvitroandinvivopharmacokineticcharacterization
AT seharshama fabricationofpolymerichydrogelscontainingesomeprazolefororaldeliveryinvitroandinvivopharmacokineticcharacterization
AT nawazasif fabricationofpolymerichydrogelscontainingesomeprazolefororaldeliveryinvitroandinvivopharmacokineticcharacterization